| 1.2 0.05 (4.35%) | 12-08 15:58 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.75 | 1-year : | 2.04 |
| Resists | First : | 1.5 | Second : | 1.75 |
| Pivot price | 1.03 |
|||
| Supports | First : | 1 | Second : | 0.69 |
| MAs | MA(5) : | 1.2  |
MA(20) : | 0.99 |
| MA(100) : | 1.62 |
MA(250) : | 3.66 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 58.3 |
D(3) : | 60.1 |
| RSI | RSI(14): 57.9 |
|||
| 52-week | High : | 11.89 | Low : | 0.17 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ FLGC ] has closed below upper band by 27.7%. Bollinger Bands are 31% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.2 - 1.21 | 1.21 - 1.21 |
| Low: | 1.07 - 1.07 | 1.07 - 1.08 |
| Close: | 1.19 - 1.2 | 1.2 - 1.21 |
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2. The company sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.
Tue, 05 Dec 2023
Is it Time to Dump Flora Growth Corp (FLGC) Stock After it Has Risen 39.76% in a Week? - InvestorsObserver
Mon, 02 Oct 2023
Flora Growth Corp. Announces Transition of Hussein Rakine from Director to Special Advisor - Yahoo Finance
Wed, 20 Sep 2023
Flora Growth Corp (FLGC) Stock Declines -50.00% This Week; Should You Buy? - InvestorsObserver
Mon, 18 Sep 2023
Global Weed Brand To Buy Australian Vaporizes For $1.7M In Shares - Flora Growth (NASDAQ:FLGC) - Benzinga
Thu, 07 Sep 2023
FLGC: Is Flora Growth (FLGC) a Good Agriculture Stock Buy Right Now? - StockNews.com
Tue, 15 Aug 2023
Transcript : Flora Growth Corp., Q2 2023 Earnings Call, Aug 15, 2023 - Marketscreener.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers—Specialty & Generic
|
|
| Shares Out | 8 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 15.2 (%) |
| Held by Institutions | 8.6 (%) |
| Shares Short | 117 (K) |
| Shares Short P.Month | 181 (K) |
| EPS | -9.77 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.75 |
| Profit Margin | -82.6 % |
| Operating Margin | -3.2 % |
| Return on Assets (ttm) | -22.2 % |
| Return on Equity (ttm) | -167.1 % |
| Qtrly Rev. Growth | 78.4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 8.82 |
| EBITDA (p.s.) | -1.89 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -0.13 |
| PEG Ratio | 0 |
| Price to Book value | 0.68 |
| Price to Sales | 0.13 |
| Price to Cash Flow | -1.2 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|